Antibiotic susceptibility testing of Staphylococcus aureus using the Biolog OmniLog® system, a metabolic phenotyping assay

Diagn Microbiol Infect Dis. 2022 Oct;104(2):115759. doi: 10.1016/j.diagmicrobio.2022.115759. Epub 2022 Jul 1.

Abstract

Use of the Biolog OmniLog® phenotyping system for antibiotic susceptibility testing (AST) was evaluated using 51 clinical isolates of Staphylococcus aureus. MIC testing by broth microdilution was compared to results generated using the OmniLog® system for oxacillin, daptomycin, vancomycin, gentamicin, linezolid, and tetracycline. There was >90% essential and categorical agreement between methods for all antibiotics, except gentamicin, which had 83.6% essential agreement, although very major errors occurred with linezolid (n = 3) and daptomycin (n = 1). Precision was satisfactory, with 5 triplicate measurements in agreement. A quantitative threshold allowed automated interpretation of MICs yielding results comparable to manual interpretation; oxacillin, gentamicin, and tetracycline resistance could be identified at a median of 7.13, 5.25, and 7.25 hours, respectively. Limitations include the small number of isolates, and especially resistant isolates tested, and the focus on a single species. Overall, the OmniLog® system was a precise method for AST of S. aureus, although accuracy was imperfect.

Keywords: OmniLog; Staphylococcus aureus; antimicrobial susceptibility testing; broth microdilution.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Daptomycin* / pharmacology
  • Gentamicins
  • Linezolid
  • Microbial Sensitivity Tests
  • Oxacillin / pharmacology
  • Staphylococcal Infections*
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Linezolid
  • Daptomycin
  • Oxacillin